IDSI Signs 8TH CT Laser Mammography Site to Complete Luminary and Research Network
10 May 2005
Imaging Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS - News) announced installation of the 8th luminary and research CT Laser Mammography system. The latest CTLM® was placed at the prestigious Gazi University Hospital, Ankara, Turkey where researchers have already begun breast scanning procedures.
A. Ozdemir, M.D., Associate Professor, Department of Radiology, said, "We are anxious to show that the CT Laser Mammography technology substantially complements the conventionally used x-ray mammography, especially in the area of functional imaging. We have a lot of experience and expertise in early breast cancer detection especially in addressing the difficulties of imaging dense breasts where ultrasound may have been the preferred imaging technique. Our findings with CTLM may be of utmost importance for imaging centers seeking to stay current with the latest imaging developments."
According to the Company the eight systems in this luminary network include:
Gazi University Hospital, Ankara, Turkey
Charles University Hospital, Prague, Czech Republic
Catholic University Hospital, Rome, Italy
Comprehensive Cancer Centre, Gliwice, Poland
Robert-Rossle Clinic, Buch, Germany
University of Muenster Hospital, Munster, Germany
Charite Hospital, Berlin, Germany
Vienna General Hospital, Vienna, Austria
Deborah O'Brien, Senior Vice President, said, "IDSI has been commercializing the CTLM in many global markets and we previously announced our plans to set up this network to foster research and to promote the technology in local markets. We will continue to support similar programs in China and in other global regions. These investments may accelerate CTLM market acceptance while providing valuable clinical experiences. With respect to Gazi, we are particularly pleased to have Professor Ozdemir in our network to focus on using CTLM as an adjunct to current procedures".
The CTLM® system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000- 13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM® system to be used as an adjunct to mammography.
Please visit Imaging Diagnostic Systems' website at: http://www.imds.com for additional information.
In conjunction with the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future anticipated projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates of future results and there can be no assurance that actual results will not materially differ from expectation. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filing with the Securities Exchange Commission.
Investor Relations:
Rick Lutz
404-261-1196
lcgroup@mindspring.com
--------------------------------------------------------------------------------
Source: Imaging Diagnostic Systems, Inc.
Source: PR Newswire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|
